Evidence map›Paper›PMID 37276821›Full record

ReviewCurrent opinion in immunology2023

Role of mouse dendritic cell subsets in priming naive CD4 T cells.

Naoya Tatsumi, Yosuke Kumamoto

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Myelin-reactive CD8Journal of neuroinflammation · 2025
    Article
  8. CD301bNature communications · 2025
    Article
  9. Fungal immunization potentiates CD4Frontiers in immunology · 2025
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Naoya TatsumiCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ, USA; Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Yosuke KumamotoCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ, USA; Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: yosuke.kumamoto@rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

Regulation of Th2 differentiation by skin-resident dendritic cellsR01AI132576 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI YOSUKE KUMAMOTO · 2017 to 2026
$3.8M
Role of cDC2 subsets in host protection and CD4T cell responses in melanomaR21CA259541 · NCI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI KUMAMOTO, YOSUKE · 2021 to 2022
$388k
NCI NIH HHS R21 CA259541NIAID NIH HHS R01 AI132576
6 · The paper itself

Abstract

Conventional dendritic cells (cDCs) are potent antigen-presenting cells that consist of developmentally, phenotypically, and functionally distinct subsets. Following immunization, each subset of cDCs acquires the antigen and presents it to CD4T (CD4

Indexed as

CD4-Positive T-LymphocytesDendritic CellsAnimalsAntigen PresentationAntigensMiceAntigens

Identifiers

PMID37276821
PMCPMC10524374
OpenAlexW4379191955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.